| Copeptin | Copeptin | Copeptin | β per 1 SD increase in copeptin |
---|---|---|---|---|
Q3-4 vs Q1-2 | Q4 vs Q1-Q3 | Q4 vs Q1 | ||
No adjustment | Â | |||
All subjects (N = 1,275) | 0.010 | 0.023 | 0.028 | 0.005 |
(-0.005; 0.026) | (0.005; 0.041) | (0.006; 0.050) | (-0.003; 0.013) | |
Men (N = 624) | -0.013 | 0.016 | 0.009 | 0.002 |
(-0.036; 0.011) | (-0.011; 0.043) | (-0.024; 0.042) | (-0.010; 0.014) | |
Women (N = 651) | 0.032 | 0.030 | 0.046 | 0.008 |
(0.012; 0.052) | (0.007; 0.053) | (0.018; 0.074) | (-0.002; 0.018) | |
Adjusted for age and sex | Â | |||
All subjects | -0.018 | -0.011 | -0.015 | -0.001 |
(-0.030; -0.006) | (-0.025; 0.003) | (-0.033; 0.002) | (-0.007; 0.005) | |
Men | -0.042 | -0.028 | -0.038 | -0.009 |
(-0.060; -0.023) | (-0.049; -0.006) | (-0.064; -0.011) | (-0.018; 0.001) | |
Women | 0.005 | 0.004 | 0.006 | 0.005 |
(-0.011; 0.020) | (-0.013; 0.022) | (-0.016; 0.027) | (-0.002; 0.013) | |
Adjusted for age, sex and BMI | Â | |||
All subjects | -0.018 | -0.012 | -0.016 | -0.002 |
(-0.030; -0.006) | (-0.026; 0.002) | (-0.033; 0.0005) | (-0.008; 0.004) | |
Men | -0.039 | -0.026 | -0.035 | -0.009 |
(-0.057; -0.020) | (-0.048; -0.005) | (-0.061; -0.009) | (-0.018; 0.0002) | |
Women | 0.002 | 0.002 | 0.003 | 0.004 |
(-0.013; 0.018) | (-0.016; 0.020) | (-0.019; 0.024) | (-0.003; 0.012) | |
Multivariable adjustment a | Â | |||
All subjects | -0.022 | -0.014 | -0.020 | -0.003 |
(-0.034; -0.010) | (-0.028; -0.0002) | (-0.037; -0.003) | (-0.009; 0.003) | |
Men | -0.038 | -0.024 | -0.035 | -0.010 |
(-0.057; -0.020) | (-0.046; -0.002) | (-0.062; -0.009) | (-0.020; -0.001) | |
Women | -0.002 | -0.001 | -0.001 | 0.004 |
(-0.017; 0.014) | (-0.019; 0.017) | (-0.023; 0.021) | (-0.004; 0.012) |